Hutchmed (China) Limited Blocklisting Six Monthly Return (1094Y)
December 29 2023 - 3:30AM
UK Regulatory
TIDMHCM
RNS Number : 1094Y
Hutchmed (China) Limited
29 December 2023
Blocklisting Six Monthly Return
Hong Kong, Shanghai, & Florham Park, NJ - Friday, December
29, 2023: HUTCHMED (China) Limited (" HUTCHMED " or the "Company")
(Nasdaq/AIM: HCM; HKEX: 13) announces the following blocklisting
six monthly return:
1. Name of applicant: HUTCHMED (China) Limited
2. Name of scheme: (a) Share Option Scheme conditionally adopted
by HUTCHMED in 2005 ("2005 HUTCHMED
Share Option Scheme")
(b) Share Option Scheme conditionally adopted
by HUTCHMED in 2015 ("2015 HUTCHMED
Share Option Scheme")
3. Period of return: From June 29, 202 3 to December 28, 202
3
4. Balance under scheme (a) 2005 HUTCHMED Share Option Scheme: 434,050
from previous return: ordinary shares of US$0.1 each
(b) 2015 HUTCHMED Share Option Scheme: 51,730,718
ordinary shares of US$0.1 each
5. The amount by which (a) 2005 HUTCHMED Share Option Scheme: Nil
the block scheme has
been increased, if
the scheme has been
increased since the
date of the last return:
(b) 2015 HUTCHMED Share Option Scheme: Nil
6. Number of securities (a) 2005 HUTCHMED Share Option Scheme: 211,320
issued/allotted under
scheme during period:
(b) 2015 HUTCHMED Share Option Scheme: 4,883,500
7. Balance under scheme (a) 2005 HUTCHMED Share Option Scheme: 222,730
not yet issued/allotted ordinary shares of US$0.1 each (Note:
at end of the period: All granted share options have been
exercised)
(b) 2015 HUTCHMED Share Option Scheme: 46,847,218
ordinary shares of US$0.1 each
8. Number and class of 25,198,880 ordinary shares of US$0.1 each
securities originally admitted on June 17, 2019 ( to replace
listed and the date the Company's previous block admission
of admission: schemes following the Company's share subdivision
which took effect on May 30, 2019)
9. Total number of securities 871,256,270 ordinary shares of US$0.1 each
in issue at the end
of the period:
Name of contact: Weiguo Su
Address of contact: Level 18, The Metropolis Tower, 10 Metropolis
Drive, Hung Hom, Kowloon, Hong Kong
Telephone number of contact: +852 2121 8200
About HUTCHMED
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative,
commercial-stage, biopharmaceutical company. It is committed to the
discovery and global development and commercialization of targeted
therapies and immunotherapies for the treatment of cancer and
immunological diseases. It has approximately 5,000 personnel across
all its companies, at the center of which is a team of about 1,800
in oncology/immunology. Since inception it has focused on bringing
drug candidates from in-house discovery to patients around the
world, with its first three medicines marketed in China, the first
of which is also marketed in the U.S. For more information, please
visit: www.hutch-med.com or follow us on LinkedIn .
CONTACTS
Investor Enquiries +852 2121 8200 / +1 973 306 4490 / ir@hutch-med.com
Media Enquiries
Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779
545 055 (Mobile) / HUTCHMED@fticonsulting.com
Zhou Yi, Brunswick +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley / Daphne Zhang, Panmure
Gordon +44 (20) 7886 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLREASAPAAKDFFA
(END) Dow Jones Newswires
December 29, 2023 03:30 ET (08:30 GMT)
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Jul 2024 to Aug 2024
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Aug 2023 to Aug 2024